Epigallocatechin-3-Gallate Enhances the Therapeutic Effects of Leptomycin B on Human Lung Cancer A549 Cells
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Epigallocatechin-3-Gallate Enhances the Therapeutic Effects of Leptomycin B on Human Lung Cancer A549 Cells
Authors
Keywords
-
Journal
Oxidative Medicine and Cellular Longevity
Volume 2015, Issue -, Pages 1-10
Publisher
Hindawi Limited
Online
2015-04-06
DOI
10.1155/2015/217304
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- CYP3A4-mediated Pharmacokinetic Interactions in Cancer Therapy
- (2015) Dandan Tian et al. CURRENT DRUG METABOLISM
- Overexpression of CRM1: A Characteristic Feature in a Transformed Phenotype of Lung Carcinogenesis and a Molecular Target for Lung Cancer Adjuvant Therapy
- (2015) Weimin Gao et al. Journal of Thoracic Oncology
- Epigallocatechin-3-gallate (EGCG) attenuates concanavalin A-induced hepatic injury in mice
- (2014) Dongmei Liu et al. ACTA HISTOCHEMICA
- ω-Hydroxyundec-9-enoic acid induces apoptosis through ROS-mediated endoplasmic reticulum stress in non-small cell lung cancer cells
- (2014) Kyung Mi Yang et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Inhibition of autophagy by chloroquine potentiates synergistically anti-cancer property of artemisinin by promoting ROS dependent apoptosis
- (2014) Arnab Ganguli et al. BIOCHIMIE
- Reversal of Cisplatin Resistance by Epigallocatechin Gallate Is Mediated by Downregulation of Axl and Tyro 3 Expression in Human Lung Cancer Cells
- (2014) Kyung-Chan Kim et al. KOREAN JOURNAL OF PHYSIOLOGY & PHARMACOLOGY
- Curcumin and Vitamin E Protect against Adverse Effects of Benzo[a]pyrene in Lung Epithelial Cells
- (2014) Wenbin Zhu et al. PLoS One
- Antitumor Effects of a Novel Chromosome Region Maintenance 1 (CRM1) Inhibitor on Non-Small Cell Lung Cancer Cells In Vitro and in Mouse Tumor Xenografts
- (2014) Shuai Wang et al. PLoS One
- Cucurbitacin B Induced ATM-Mediated DNA Damage Causes G2/M Cell Cycle Arrest in a ROS-Dependent Manner
- (2014) Jiajie Guo et al. PLoS One
- Reactive oxygen species contribute to arsenic-induced EZH2 phosphorylation in human bronchial epithelial cells and lung cancer cells
- (2014) Lingzhi Li et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- Green tea catechin, epigallocatechin-3-gallate, attenuates the cell viability of human non-small-cell lung cancer A549 cells via reducing Bcl-xL expression
- (2014) JUN-ICHIRO SONODA et al. Experimental and Therapeutic Medicine
- Effects of Epigallocatechin-3-gallate (EGCG) on A549 Lung Cancer Tumor Growth and Angiogenesis
- (2013) Yuhi SAKAMOTO et al. BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY
- Zebularine inhibits the growth of A549 lung cancer cells via cell cycle arrest and apoptosis
- (2013) Bo Ra You et al. MOLECULAR CARCINOGENESIS
- CRM1 Is a Cellular Target of Curcumin: New Insights for the Myriad of Biological Effects of an Ancient Spice
- (2013) Mingshan Niu et al. TRAFFIC
- Survivin knockdown increased anti-cancer effects of (−)-epigallocatechin-3-gallate in human malignant neuroblastoma SK-N-BE2 and SH-SY5Y cells
- (2012) Md. Motarab Hossain et al. EXPERIMENTAL CELL RESEARCH
- Inherited variations in theSODandGPXgene families and cancer risk
- (2012) Arseniy E. Yuzhalin et al. FREE RADICAL RESEARCH
- Green tea polyphenol epigallocatechin-3-gallate enhances 5-fluorouracil-induced cell growth inhibition of hepatocellular carcinoma cells
- (2012) Xue-Wei Yang et al. HEPATOLOGY RESEARCH
- Delphinidin-3-O-galactoside protects mouse hepatocytes from (−)-epigallocatechin-3-gallate–induced cytotoxicity via up-regulation of heme oxygenase-1 and heat shock protein 70
- (2012) Hirofumi Inoue et al. NUTRITION RESEARCH
- Epigallocatechin gallate sensitizes CAL-27 human oral squamous cell carcinoma cells to the anti-metastatic effects of gefitinib (Iressa) via synergistic suppression of epidermal growth factor receptor and matrix metalloproteinase-2
- (2012) CHIA-MING CHANG et al. ONCOLOGY REPORTS
- Chemotherapeutic Sensitization of Leptomycin B Resistant Lung Cancer Cells by Pretreatment with Doxorubicin
- (2012) Chuanwen Lu et al. PLoS One
- CBS9106 is a novel reversible oral CRM1 inhibitor with CRM1 degrading activity
- (2011) K. Sakakibara et al. BLOOD
- Epigallocatechin-3-O-gallate (EGCG) attenuates FFAs-induced peripheral insulin resistance through AMPK pathway and insulin signaling pathway in vivo
- (2011) Yan Li et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- (-)-Epigallocatechin-3-gallate induces apoptosis in gastric cancer cell lines by down-regulating survivin expression
- (2011) Watanabe INTERNATIONAL JOURNAL OF ONCOLOGY
- The role of antioxidant versus pro-oxidant effects of green tea polyphenols in cancer prevention
- (2011) Sarah C. Forester et al. MOLECULAR NUTRITION & FOOD RESEARCH
- p53-dependent anticancer effects of leptomycin B on lung adenocarcinoma
- (2010) Changxia Shao et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- New cancer treatment strategy using combination of green tea catechins and anticancer drugs
- (2010) Masami Suganuma et al. CANCER SCIENCE
- Pro-oxidative activities and dose–response relationship of (−)-epigallocatechin-3-gallate in the inhibition of lung cancer cell growth: a comparative study in vivo and in vitro
- (2010) Guang-Xun Li et al. CARCINOGENESIS
- Targeted Therapies for Non-Small Cell Lung Cancer: An Evolving Landscape
- (2010) S. K. Pal et al. MOLECULAR CANCER THERAPEUTICS
- Survivin withdrawal by nuclear export failure as a physiological switch to commit cells to apoptosis
- (2010) K-S Chan et al. Cell Death & Disease
- Identification of Nuclear Export Inhibitors with Potent Anticancer Activity In vivo
- (2009) S. C. Mutka et al. CANCER RESEARCH
- Targeted therapies for non-small cell lung cancer
- (2009) Wolfram C.M. Dempke et al. LUNG CANCER
- Antioxidant effects of green tea and its polyphenols on bladder cells
- (2008) Christian H. Coyle et al. LIFE SCIENCES
- EGCG inhibits growth, invasion, angiogenesis and metastasis of pancreatic cancer
- (2007) Sharmila Shankar Frontiers in Bioscience-Landmark
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now